|Articles|November 3, 2016
EUPATI Prepares to Celebrate 5th Anniversary in Brussels
Author(s)Philip Ward
EUPATI celebrates its 5th Anniversary in Brussels by staging a free workshop.
Advertisement
As the fifth anniversary of the European Patients’ Academy (EUPATI) approaches, the organization is getting to stage a free workshop, “All Aboard to a Better Health Future”, to be held in Brussels on December 14th.
According to a statement from EUPATI, “Patient involvement in medicines research and development is a major driving force for transformational change in healthcare and the development of innovative medicines. This is why the EUPATI Project is such an exciting and unique opportunity – offering patients and patient advocates education and information on how new therapies are being developed and regulated.”
EUPATI works at the national level, implementing initiatives in 18 countries. The national teams offer workshops and tutorials for patient groups, interacting with professionals from clinical research, ethics committees, regulators, and the pharmaceutical industry.
According to a statement from EUPATI, “Patient involvement in medicines research and development is a major driving force for transformational change in healthcare and the development of innovative medicines. This is why the EUPATI Project is such an exciting and unique opportunity – offering patients and patient advocates education and information on how new therapies are being developed and regulated.”
EUPATI works at the national level, implementing initiatives in 18 countries. The national teams offer workshops and tutorials for patient groups, interacting with professionals from clinical research, ethics committees, regulators, and the pharmaceutical industry.
“The challenge now is to bring all these initiatives and experiences together to create value for everyone. For the patient this means better understanding of research and innovation, leading to better therapies and eventually to improved health and well being,” EUPATI noted.
EUPATI is a pan-European Innovative Medicines Initiative (http://www.imi.europa.eu/ ) project of 33 organizations, led by the European Patients’ Forum, with partners from patient organizations (the European Genetic Alliance, the European AIDS Treatment Group, and EURORDIS), universities and not-for-profit organizations, along with a number of pharmaceutical companies.
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Articles
- eClinical Technology: Misconceptions, Challenges, and Opportunities
September 9th 2025
- How Sponsors Can Modernize Tools to Support Physicians
September 9th 2025
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
AstraZeneca’s Tagrisso Shows Landmark Overall Survival Benefit in Non-Small Cell Lung Cancer
2
Investigational OX40-Targetting T-Cell Therapy Shows Durable Efficacy Treating Atopic Dermatitis in Phase III Trial
3
Pfizer, BioNTech’s Comirnaty Shows Strong Immune Response in Phase III Trial for COVID-19
4
Phase III EMPOWER-Lung 3 Trial Confirms Five-Year Survival Benefit With Libtayo Plus Chemotherapy in NSCLC
5